We recently established a novel co-culture assay system using activated inflammatory cells and AS52 Chinese hamster ovary cells, and demonstrated that reactive oxygen and nitrogen species (RONS) generated from activated inflammatory leukocytes induce mutations in the gpt recorder gene in AS52 cells. In this study, we examined the inhibitory effects of 19 agents with antioxidative properties on RONS generation in cultured inflammatory cells and on mutagenesis in AS52 cells co-cultured with activated inflammatory cells. The results demonstrate that there is a linear correlation between the ability of these agents to suppress RONS production in activated inflammatory cells and to inhibit mutation in AS52 cells.
Excess production of reactive oxygen and nitrogen species (RONS) generated from activated inflammatory leukocytes, especially under conditions of chronic inflammation, may have an important role in tumor initiation and promotion and inhibitors that block the generation of RONS may block or delay carcinogenic processes. 1) Thus, inhibition of RONS generation by antioxidants including food phytochemicals is regarded as one of the promising avenues for cancer control. Suppression of superoxide (O 2 À ) and nitric oxide (NO) generation is considered to be important in reducing or mitigating oxidative stress, because they are the initial free radicals in a variety of RONS-producing pathways and react rapidly with each other to form peroxynitrite (ONOO À ) which is much more toxic than other types of RONS. 2, 3) To search for O 2 À and NO generation inhibitors, several in vitro assay systems using inflammatory cells have already been established. 12-OTetradecanoylphorbol-13-acetate (TPA) activates dimethylsulfoxide (DMSO)-differentiated HL-60 (human promyelocytic leukemia cells) to induce the NADPH oxidase activity, leading to O 2 À generation. 4) Similarly, bacterial lipopolysaccharide (LPS) and interferon (IFN)-, alone or in combination, induce the production both of O 2 À and NO from inducible nitric oxide synthase (iNOS) in macrophages, including RAW 264.7 cells. 5) Previously, several phytochemicals have been isolated and identified in our laboratory as functionally novel cancer chemopreventive agents with RONS generation suppressive properties. [6] [7] [8] [9] [10] [11] [12] [13] We recently established a novel co-culture assay system using activated inflammatory cells with AS52 Chinese hamster ovary cells, and demonstrated that RONS generated from activated inflammatory leukocytes are mutagenic toward AS52 cells. 14) Briefly, TPAstimulated, differentiated HL-60 cells or LPS/IFN--stimulated RAW 264.7 cells induced mutations in the xanthine-guanine phosphoribosyltransferase (gpt) recorder gene in co-cultured AS52 cells, and the increased mutation frequency was markedly suppressed by RONS generation inhibitors.
In this study, the correlation between RONS generation inhibition in inflammatory leukocytes and suppression of mutagenesis was investigated using this coculture assay system. We examined the inhibitory effects of a total of 19 antioxidants on O À was measured using a cytochrome c reduction method. 14) As for O 2 À /NO generation inhibition in RAW 264.7, cells were stimulated with both LPS (100 ng/ml) and IFN-(100 U/ml) in the presence or absence of test compounds, and NO generation was evaluated by the Griess method.
14) The formation of ONOO À was measured by the ONOO-dependent oxidation of dihydrorhodamine 123 to rhodamine 123. 15) In the mutation assay, TPAstimulated, differentiated HL-60 cells or LPS/IFN--stimulated RAW 264.7 cells were co-cultured with AS52 cells at a ratio of 1:1 in the presence or absence of test compounds, and the AS52 mutants carrying gpt mutation were selected by 6-thioguanine. 14) As shown in Table 1, 1 0 -acetoxychavicol acetate (ACA), diphenylene iodonium (DPI, an NADPH competitor), nobiletin, -tocopherol, curcumin, superoxide dismutase (SOD), zerumbone, and auraptene, strongly inhibited O 2 À generation in TPA-stimulated HL-60 cells (inhibition rates: IRs = 93.0, 92.1, 87.8, 87.0, 83.9, 83.6, 71.9, and 70.3%, respectively), and (À)-catechin, silymarin, (À)-epigallochatechin gallate (EGCG), benzylisothiocyanate (BITC) and ferulic acid showed moderate inhibition (IRs = 67.7, 67.3, 64.4, 63.1 and 51.3%, respectively). In mutation assay, silymarin, curcumin, ACA, zerumbone, auraptene, nobiletin, EGCG, capsaicin and -tocopherol had significant decreases in mutations in the gpt gene in AS52 cells (IRs = 100, 100, 100, 98.3, 94.2, 88.5, 83.9, 80.6, and 78.5%, respectively). .0 and 75.3%, respectively). In the mutation assay, -tocopherol, curcumin, DPI, L-NIO, (À)-catechin, nobiletin, silymarin, and ACA markedly suppressed the mutations (IRs = 100, 100, 100, 100, 90.6, 80.6, 79.7, and 78.6%, respectively).
The correlation between RONS generation inhibition in stimulated HL-60 or RAW 264.7 cells and the suppression of mutagenesis in co-cultured AS52 cells is illustrated in Fig. 1 . Inhibition rate of RONS generation in HL-60 cell line is linearly correlated with the suppression of mutagenesis in AS52 cells, whereas HL-60 cells (10 6 ) were incubated with samples at 37 C for 15 min, and then treated with TPA (100 nM) for another 15 min. The extracelluar O 2 À was measured using a cytochrome c reduction method. In the mutation assay, differentiated HL-60 cells (5 Â 10 5 ) were co-cultured with AS52 cells at a ratio of 1:1. The cells were treated with TPA (100 nM) and antioxidants for 1 h. Mutational analyses were done as described in previous report. 14) Data are shown as mean AE standard deviation.
The inhibition rate (IR) and cell viability (CV) in each assay was calculated by the following equations: IR(%) = {1 À [(test sample date) À (negative control data)][(positive control data) À (negative control data)] 1 } Â 100; CV(%) = {1 À [(test sample data) À (negative control data)][(positive control data) À (negative control data)]
1 } Â 100. a P < 0:01 vs. TPA. (Figs. 1B and 1C) . Nonetheless, DPI (17) and L-NIO (19), both iNOS inhibitors, strongly suppressed the mutation frequencies, indicating iNOS in LPS/IFN--stimulated RAW 264.7 cells is a major source for inducing mutation. Interestingly, -tocopherol (1), inhibiting both O 2 À and ONOO À , but not NO, generation also suppressed the mutation frequency (Figs. 1B-1D (12) , zerumbone (13) , nobiletin (14) , and auraptene (15) even at a concentration of 10 M showed comparable or higher anti-oxidative and anti-mutagenic properties than other compounds (100 M). Compounds such as Lascorbic acid (5) and allopurinol (18), a xanthine oxidase inhibitor, that are weak suppressors of RONS generation had little, if any, effect on mutagenesis. Unexpectedly, however, (À)-catechin (3) showed a notable mutation suppression (IR = 90.6%) although it is not a distinct RONS generation inhibitor (IR = 20.1% $ 58.5%), implicating alterative anti-oxidative mechanism for anti-mutagenesis. There are at least 4 notes of action for the reduction of RONS production: 1) radical scavenging by directly reacting with RONS; 2) inhibition of RONS generating enzyme induction, for instance, the expression of enzyme proteins and assembly of enzyme components; 3) inhibition of enzyme reactions; and 4) induction of antioxidant enzymes. These issues should be approached in the next study.
In conclusion, this study strongly support the idea that inhibition of RONS generated from activated inflammatory leukocytes is closely related with suppression of mutagenesis in mammalian cells, and that antioxidative compounds including food phytochemicals such as silymarin, ACA, zerumbone, nobiletin, and auraptene have anti-mutagenic potentials and these agents may be useful in therapy of chronic inflammation-associated carcinogenesis. The levels of O 2 À , NO, and ONOO À were measured by cytochrome c reduction method, Griess method and dehydrorhodamine 123 method, respectively, as described previously. 14) In the mutation assay, RAW264.7 cells (5 Â 10 5 ) were co-cultured with AS52 cells at a ratio of 1:1. The cells were treated with LPS (100 ng/ml)/IFN-(100 U/ml) and samples for 24 h. Mutational analyses were performed as described in previous report. 14) Data are shown as meanAEstandard deviation.
The inhibition rate (IR) and cell viability (CV) in each assay were calculated by the following equations: IR(%) = {1 À [(test sample date) À (negative control data)][(positive control data) À (negative control data)] À1 } Â 100; CV(%) = {1 À [(test sample data) À (negative control data)][(positive control data) À (negative control data)] À1 } Â 100. a P < 0:01 vs. TPA. b P < 0:05 vs. TPA. The statistical significance of differences between groups in each assay was assessed by a Student's t-test. c 10 M. d 100 U/ml. e 1 mM.
